Revolution Medicines (RVMD) Treasury Shares (2019 - 2026)

Revolution Medicines' Treasury Shares history runs 8 years deep, the most recent figure standing at $5.1 million for Q1 2026.

• On a quarterly basis, Treasury Shares rose 33.82% year-over-year to $5.1 million in Q1 2026; TTM through Mar 2026 was $5.1 million, a 33.82% increase from a year earlier, with the FY2025 full-year figure at $3.9 million, up 36.56% from the prior year.
• Treasury Shares rose to $5.1 million in Q1 2026 per RVMD's latest filing, from $3.9 million in the prior quarter.
• Across five years, Treasury Shares topped out at $5.1 million in Q1 2026 and bottomed at $1.1 million in Q1 2022.
• The 5-year median for Treasury Shares is $2.9 million (2024), against an average of $2.7 million.
• Across the five-year window, Treasury Shares surged 223.62% in 2022 and gained 19.76% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $1.2 million in 2022, then soared by 83.93% to $2.2 million in 2023, then soared by 31.87% to $2.9 million in 2024, then surged by 36.56% to $3.9 million in 2025, then jumped by 32.12% to $5.1 million in 2026.
• Per Business Quant, the three latest RVMD Treasury Shares figures stand at $5.1 million (Q1 2026), $3.9 million (Q4 2025), and $3.8 million (Q3 2025).